CLAYTON REID: Open Payments
NPI 1285215319 · COMMERCE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 9 payments from 7 companies in 2025. Trend: 2023 $100 · 2024 $235 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Dexcom, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
Products named: JOURNAVX, FARXIGA, Dexcom G6 Transmitter, Cologuard Collection Kit, AIRSUPRA, CAPLYTA, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
